FILE PHOTO: A medical specialist holds a vial of Sputnik V vaccine against the coronavirus in a department store in Moscow, Russia, January 18, 2021 REUTERS/Shamil Zhumatov
SANTIAGO (Reuters) - The director of Chile’s health regulator said he sees no evidence of safety issues with Sputnik V, the COVID-19 vaccine developed in Russia, despite its rejection by the Brazilian health regulator this week over a lack of information about its safety.
Heriberto Garcia, the director of Chile's Public Health Institute (ISP), said Chile was seeking clarity from the vaccine's developers about the potential presence of an adenovirus that could reproduce, possibly creating a negative reaction in recipients. This was the basis for Brazil's health regulator, Anvisa, rejecting the vaccine on Monday.
Subscribe now and receive FREE sooka plan for 1 month.
T&C applies.
